Aydin, S.; Schmitz, J.; Dellacasa, C.M.; Dogliotti, I.; Giaccone, L.; Busca, A.
WT1 Expression Is Associated with Poor Overall Survival after Azacytidine and DLI in a Cohort of Adult AML and MDS Patients. Cancers 2024, 16, 3070.
https://doi.org/10.3390/cancers16173070
AMA Style
Aydin S, Schmitz J, Dellacasa CM, Dogliotti I, Giaccone L, Busca A.
WT1 Expression Is Associated with Poor Overall Survival after Azacytidine and DLI in a Cohort of Adult AML and MDS Patients. Cancers. 2024; 16(17):3070.
https://doi.org/10.3390/cancers16173070
Chicago/Turabian Style
Aydin, Semra, Jennifer Schmitz, Chiara M. Dellacasa, Irene Dogliotti, Luisa Giaccone, and Alessandro Busca.
2024. "WT1 Expression Is Associated with Poor Overall Survival after Azacytidine and DLI in a Cohort of Adult AML and MDS Patients" Cancers 16, no. 17: 3070.
https://doi.org/10.3390/cancers16173070
APA Style
Aydin, S., Schmitz, J., Dellacasa, C. M., Dogliotti, I., Giaccone, L., & Busca, A.
(2024). WT1 Expression Is Associated with Poor Overall Survival after Azacytidine and DLI in a Cohort of Adult AML and MDS Patients. Cancers, 16(17), 3070.
https://doi.org/10.3390/cancers16173070